Notably, we show that the progressive growth of PIK3CAH1047R-driven microcystic LM is dependent on the upstream lymphangiogenic VEGF-C/VEGFR3 signaling, which permits a novel effective therapeutic intervention to treat LM. Here, VEGFC is linked to lymphangioma.